MedPath

Comparison of outcomes in patients undergoing SMILE surgery for refractive errors using two different cones

Not yet recruiting
Conditions
Myopia, (2) ICD-10 Condition: H526||Other disorders of refraction,
Registration Number
CTRI/2019/01/017149
Lead Sponsor
Dr Sri Ganesh
Brief Summary

The present contralateral eye study would be conducted with the aim of assessing the outcomes and visual quality using medium versus small sized cone for docking during the procedure of Relex Smile with large corneal diameters for myopia correction .moreover ,to compare clinical outcomes including immediate visual quality, contrast sensitivity, aberrations,corneal biomechanics and patient satisfaction

Thirty patients fulfilling the inclusion criteria will be enrolled in the study.righ and left eye of the patient will be randomised into two groups ,in one eye medium sized cone and other eye small sized cone will be used .energy parameters in both eyes will be same



Post surgery patients will be followed up on day 1 , 2 weeks and 3 months , the pre -operative investigations will be repeated during the follow up visits and adverse events will be documented and duly informed to Ethics Committee.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1.patients with myopia with or without astigmatism 2.manifest spherical equivalent between 3-10 diopters 3.stable refraction of less than 0.50 D change in last 1 year 4.white to white diameter more than or equal to 12 mm 5.cdva of 6/6 0r better in both eyes 6.residual stroll bed thickness of 280 micron or more 7.ability to understand and willingness to sign inform consent and participate in follow up visits.

Exclusion Criteria

1.patient not able to lie in horizontal position 2.patient not able to understand and give informed consent 3.significant dry eye or lid and adnexal disease 4.herpes viral infection 5.diabetes 6.pregnant or nursing women 7.patients with a weight of more than 135kg 8.treatment with systemic medication which influence wound healing 9.medication with the active substance isotretinoin 10.previous intraocular or corneal surgery 11.disorder of cornea 12.keratoconus 13.corneal dystrophies 14.corneal scars 15.cataract 16.glaucoma suspect 17.patients with unstable refractive error 18.anisometropia of 2D or more 19.residual stroll bed thickness less than 250 micron 20.patient who have undergone cataract surgery 21.age related macular degeneration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinical outcome and visual quality (time frame : pre-operative visit,1st day,15 days and 3months follow-uppre-operative visit,1st day,15 day & 3 months follow-up
A lower LogMAR value indicates better visual acuitypre-operative visit,1st day,15 day & 3 months follow-up
uncorrected visual acuity (time frame :pre-operative,1 day,15 day & 3months follow-up)pre-operative visit,1st day,15 day & 3 months follow-up
best corrected visual acuity (time frame: 1 day , 15 day & 3months follow-up)pre-operative visit,1st day,15 day & 3 months follow-up
lower OSI value indicates better visual qualitypre-operative visit,1st day,15 day & 3 months follow-up
Secondary Outcome Measures
NameTimeMethod
Any adverse eventsday 1, day 15, 3months

Trial Locations

Locations (1)

Nethradhama Superspeciality eye hospital

🇮🇳

Bangalore, KARNATAKA, India

Nethradhama Superspeciality eye hospital
🇮🇳Bangalore, KARNATAKA, India
Dr Sri Ganesh
Principal investigator
9845129740
phacomaverick@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.